| Odds ratio | 95% confidence interval | P value |
---|---|---|---|
Age | 1.009 | 0.982–1.036 | Not significant |
Female gender | 1.014 | 0.965–1.123 | Not significant |
Total-cholesterol | 0.998 | 0.990–1.006 | Not significant |
Low-density lipoprotein-cholesterol | 0.960 | 0.991–1.010 | Not significant |
High-density lipoprotein-cholesterol | 0.969 | 0.931–1.008 | Not significant |
Triglycerides | 0.998 | 0.991–1.006 | Not significant |
Apolipoprotein B-100 | 1.012 | 0.934–1.134 | Not significant |
Apolipoprotein A-I | 0.985 | 0.876–1.078 | Not significant |
Antibodies against oxidized low-density lipoprotein in the lag phase | 0.027 | 0.004–0.177 | 0.000 |
Antibodies against oxidized low-density lipoprotein in the propagation phase | 0.029 | 0.005–0.171 | 0.000 |
Antibodies against oxidized low-density lipoprotein in the decomposition phase | 0.034 | 0.008–0.152 | 0.000 |
Plasma lipoprotein phospholipase A2 activity | 1.038 | 1.012–1.066 | 0.004 |
High-density lipoprotein-associated lipoprotein phospholipase A2 activity | 1.021 | 0.897–1.245 | Not significant |